Daily Podcasts Video Research

Biden’s Cancer Battle

JL;DR SUMMARY Dr. Michael Zelefsky, a leading expert in prostate cancer, discusses the implications of President Biden's prostate cancer diagnosis, explaining the aggressiveness of high-risk Gleason 9 cancers and the importance of early detection and targeted treatment. A way out west there was a fella, fella I want to tell you about, fella by the name of Jeff Lebowski. At least, that was the handle his lovin' parents gave him, but he never had much use for it himself. This Lebowski, he called himself the Dude. Now, Dude, that's a name no one would self-apply where I come from. But then, there was a lot about the Dude that didn't make a whole lot of sense to me. And a lot about where he lived, likewise. But then again, maybe that's why I found the place s'durned innarestin'.

JL;DR members get full summaries of all articles in the archive, including this one. Donate & start reading »

Tags

Joe BidenProstate CancerMedical AdvancementsMichael ZelefskyRadiation OncologyGleason ScoreHormonal TherapyMetastasisTheranosticsDiagnosis Uncertainty

Places mentioned

New York, United States
"Currently, Dr. Zelefsky directs the prostate radiation oncology program at NYU, where he utilizes cutting-edge technology to deliver precise, highly targeted treatments for localized prostate cancer."
Israel
"I also consult regularly with many other rabbinic leaders, some in Eretz Yisrael, such as Rav Yitzchak Zilberstein, Rav Asher Weiss and the Amshinover Rebbe, among others."
This item was indexed and curated by Cairo, JL;DR's web crawler.
Cairo Item ID 53924
Cairo Source ID 4
Retrieved 2025-06-12 05:30:25 UTC
Curated 2025-06-12 08:31:30 UTC